Cyster, J.G.: Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu. Rev. Immunol. 2005, 23:127–159.
Idzko, M., Hammad, H., van Nimwegen, M., Kool, M., Muller, T., Soullie, T., Willart, M.A., Hijdra, D., Hoogsteden, H.C., and Lambrecht, B.N.: Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function. J. Clin. Invest. 2006, 116:2935–2944.
Kappos, L., Radue, E.W., O’Connor, P., Polman, C., Hohlfeld, R., Calabresi, P., Selmaj, K., Agoropoulou, C., Leyk, M., Zhang-Auberson, L., et al.: A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N. Engl. J. Med. 2010, 362:387–401.
Podolsky, D.K.: Selective adhesion-molecule therapy and inflammatory bowel disease—a tale of Janus? N. Engl. J. Med. 2005, 353:1965–1968.
16-10 Blockade of co-stimulatory pathways that activate lymphocytes can be used to treat autoimmune disease.
Fife, B.T., and Bluestone, J.A.: Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways. Immunol. Rev. 2008, 224:166–182.
Ellis, C.N., and Krueger, G.G.: Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes. N. Engl. J. Med. 2001, 345:248–255.
Menter, A.: The status of biologic therapies in the treatment of moderate to severe psoriasis. Cutis 2009, 84:14–24.
Kraan, M.C., van Kuijk, A.W., Dinant, H.J., Goedkoop, A.Y., Smeets, T.J., de Rie, M.A., Dijkmans, B.A., Vaishnaw, A.K., Bos, J.D., and Tak, P.P.: Alefacept treatment in psoriatic arthritis: reduction of the effector T cell population in peripheral blood and synovial tissue is associated with improvement of clinical signs of arthritis. Arthritis Rheum. 2002, 46:2776–2784.
Lowes, M.A., Chamian, F.,Abello, M.V., Fuentes-Duculan, J., Lin, S.L., Nussbaum, R., Novitskaya, I., Carbonaro, H., Cardinale, I., Kikuchi, T., et al.: Increase in TNF-α and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a). Proc. Natl Acad. Sci. USA 2005, 102:19057–19062.
16-11 Some commonly used drugs have immunomodulatory properties.
Baeke, F., Takiishi, T., Korf, H., Gysemans, C., and Mathieu, C.: Vitamin D: modulator of the immune system. Curr. Opin. Pharmacol. 2010, 10:482–496.